Your browser doesn't support javascript.
loading
Durable Response to Vismodegib in PTCH1 F1147fs Mutant Relapsed Malignant Pleural Mesothelioma: Implications for Mesothelioma Drug Treatment.
Popat, Sanjay; Sharma, Bhupinder; MacMahon, Suzanne; Nicholson, Andrew G; Sharma, Rajaei K; Schuster, Klaus; Lang Lazdunski, Loic; Fennell, Dean.
Afiliación
  • Popat S; Royal Marsden Hospital NHS Foundation Trust, London, United Kingdom.
  • Sharma B; Section of Clinical Studies, Institute of Cancer Research, London, United Kingdom.
  • MacMahon S; National Centre for Mesothelioma Research, National Heart & Lung Institute, Imperial College London, London, United Kingdom.
  • Nicholson AG; Royal Marsden Hospital NHS Foundation Trust, London, United Kingdom.
  • Sharma RK; Royal Marsden Hospital NHS Foundation Trust, London, United Kingdom.
  • Schuster K; Section of Clinical Studies, Institute of Cancer Research, London, United Kingdom.
  • Lang Lazdunski L; National Centre for Mesothelioma Research, National Heart & Lung Institute, Imperial College London, London, United Kingdom.
  • Fennell D; Department of Histopathology, Royal Brompton & Harefield NHS Foundation Trust, London, United Kingdom.
JCO Precis Oncol ; 5: 39-43, 2021 11.
Article en En | MEDLINE | ID: mdl-34994590

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Piridinas / Receptor Patched-1 / Mesotelioma Maligno / Anilidas / Recurrencia Local de Neoplasia Límite: Humans / Male / Middle aged Idioma: En Revista: JCO Precis Oncol Año: 2021 Tipo del documento: Article País de afiliación: Reino Unido

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Piridinas / Receptor Patched-1 / Mesotelioma Maligno / Anilidas / Recurrencia Local de Neoplasia Límite: Humans / Male / Middle aged Idioma: En Revista: JCO Precis Oncol Año: 2021 Tipo del documento: Article País de afiliación: Reino Unido